Prognostic Implication of Admission HbA1c for All-cause Mortality in Ischemic Heart Failure among a Chinese Population: A Prospective Cohort Study

Weida Qiu,Sicheng Chen,Anping Cai,Xiaoju Xiao,Zhiping Gao,Jijin Lin,Liwen Li

DOI: https://doi.org/10.21203/rs.3.rs-728195/v1

2021-01-01

Abstract:Background: The impact of glycosylated hemoglobin A1c (HbA1c) on heart failure (HF) and ischemic heart disease (IHD) differs among studies, and IHD is a preponderant cause in HF. We investigated the link between admission HbA1c and all-cause mortality in a Chinese population with ischemic heart failure (IHF).Methods: Eligible patients with IHF at the Department of Cardiology, Guangdong Provincial People’s Hospital from December 2015 to June 2019 were enrolled to investigate the association between admission HbA1c and all-cause mortality of IHF with Kaplan-Meier survival analysis and Cox regression analysis.Results: Of 1413 participants, the median age was 63.2 ± 10.9 years, 85% were men and median admission HbA1c level was 6.82%. All-cause mortality was higher in HbA1c >7% group compared with HbA1c ≤7% group (hazard ratio (HR): 1.328, 95% confidence interval (CI): 1.016-1.735, p =0.037), and sensitivity analysis appeared the consistent result. The association between HbA1c and all-cause mortality was also statistically significant in the male and younger cohorts.Conclusions: Elevated admission HbA1c level (>7%) is an independent risk factor for all-cause mortality of IHF in the general population, and there is also a consistent trend among male and younger individuals. Further explorations are required to elucidate whether glycemic management plays a crucial role in the progression of IHF within female and elderly population.